Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic beryllium disease: a hypersensitivity disorder.

M D Rossman1

  • 1Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania Medical Center, Philadelphia, USA.

Applied Occupational and Environmental Hygiene
|May 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HLA and environmental interactions in sarcoidosis.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2009
Same author

Justification for screening for chronic beryllium disease: closer to reality.

The European respiratory journal·2008
Same author

Genome-wide search for sarcoidosis susceptibility genes in African Americans.

Genes and immunity·2005
Same author

Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).

American journal of respiratory and critical care medicine·2001
Same author

Clinical characteristics of patients in a case control study of sarcoidosis.

American journal of respiratory and critical care medicine·2001
Same author

Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders?

Nuclear medicine communications·2001

Chronic beryllium disease (CBD) is an immune-related lung condition caused by beryllium exposure. Research confirms CBD is a hypersensitivity disorder, crucial for diagnosis and prevention.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Occupational Health

Background:

  • Chronic beryllium disease (CBD) is a lung condition resulting from environmental beryllium exposure.
  • Early observations suggested a hypersensitivity reaction due to delayed skin tests and granulomatous inflammation.

Purpose of the Study:

  • To confirm the hypothesis that CBD is caused by beryllium hypersensitivity.
  • To elucidate the immunological mechanisms and genetic associations involved in CBD pathogenesis.

Main Methods:

  • Bronchoalveolar lavage cell sampling and lymphocyte proliferation assays.
  • Analysis of CD4+ lymphocyte responses to beryllium peptides presented by HLA molecules.
  • Genetic association studies focusing on HLA-DPB1 alleles.

Related Experiment Videos

Main Results:

  • Confirmed CBD is a hypersensitivity disorder through lymphocyte proliferation assays.
  • Identified accumulation of beryllium-responsive lymphocytes at the disease site.
  • Found a strong association between CBD and specific HLA-DPB1 alleles (Gln69).

Conclusions:

  • CBD is definitively an immune-mediated hypersensitivity disorder.
  • Understanding the immunological basis impacts diagnostic strategies and prevention.
  • Genetic predisposition, particularly HLA-DPB1, plays a significant role in CBD development.